News
Research indicates GLP-1 receptor agonists, like Ozempic, may elevate testosterone levels in men while promoting weight loss.
Pre-diabetes now affects as many as one-third of children ages 12-17. As a physician this is why Ozempic should still not be ...
Lawmakers are trying to restore access to GLP-1 weight loss drugs, like Ozempic and Wegovy, after Ohio removed medical ...
A new study finds four factors that may make it more likely for some people to experience successful weight loss from using ...
Weight-loss injections, including popular drugs like Wegovy and Mounjaro, may offer a protective shield against serious ...
A new study of 60,000 people around the world is shedding light on the possible brain health benefits of popular weight-loss ...
If you’ve been taking Ozempic or Wegovy (both of which contain the active ingredient semaglutide), you might wonder, How long ...
Relying on Ozempic or Mounjaro to keep your weight in check can result in other issues, such as muscle wastage instead of fat ...
Most policies still exclude weight-loss medications under general exclusions unless they are part of the treatment of a ...
New research finds that men taking a GLP-1 for their obesity or type 2 diabetes often experience a rise in testosterone levels.
British Columbia's Ministry of Health is limiting the sales of two more diabetes drugs to curb their off-label use for weight ...
Ongoing research is needed to fully understand their risks, especially for long-term and higher-dose users. However, many ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results